Vaccinia Virus–Encoded Ribonucleotide Reductase Subunits Are Differentially Required for Replication and Pathogenesis
Ribonucleotide reductases (RRs) are evolutionarily-conserved enzymes that catalyze the rate-limiting step during dNTP synthesis in mammals. RR consists of both large (R1) and small (R2) subunits, which are both required for catalysis by the R12R22 heterotetrameric complex. Poxviruses also encode RR proteins, but while the Orthopoxviruses infecting humans [e.g. vaccinia (VACV), variola, cowpox, and monkeypox viruses] encode both R1 and R2 subunits, the vast majority of Chordopoxviruses encode only R2 subunits. Using plaque morphology, growth curve, and mouse model studies, we investigated the requirement of VACV R1 (I4) and R2 (F4) subunits for replication and pathogenesis using a panel of mutant viruses in which one or more viral RR genes had been inactivated. Surprisingly, VACV F4, but not I4, was required for efficient replication in culture and virulence in mice. The growth defects of VACV strains lacking F4 could be complemented by genes encoding other Chordopoxvirus R2 subunits, suggesting conservation of function between poxvirus R2 proteins. Expression of F4 proteins encoding a point mutation predicted to inactivate RR activity but still allow for interaction with R1 subunits, caused a dominant negative phenotype in growth experiments in the presence or absence of I4. Co-immunoprecipitation studies showed that F4 (as well as other Chordopoxvirus R2 subunits) form hybrid complexes with cellular R1 subunits. Mutant F4 proteins that are unable to interact with host R1 subunits failed to rescue the replication defect of strains lacking F4, suggesting that F4-host R1 complex formation is critical for VACV replication. Our results suggest that poxvirus R2 subunits form functional complexes with host R1 subunits to provide sufficient dNTPs for viral replication. Our results also suggest that R2-deficient poxviruses may be selective oncolytic agents and our bioinformatic analyses provide insights into how poxvirus nucleotide metabolism proteins may have influenced the base composition of these pathogens.
Vyšlo v časopise:
Vaccinia Virus–Encoded Ribonucleotide Reductase Subunits Are Differentially Required for Replication and Pathogenesis. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000984
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000984
Souhrn
Ribonucleotide reductases (RRs) are evolutionarily-conserved enzymes that catalyze the rate-limiting step during dNTP synthesis in mammals. RR consists of both large (R1) and small (R2) subunits, which are both required for catalysis by the R12R22 heterotetrameric complex. Poxviruses also encode RR proteins, but while the Orthopoxviruses infecting humans [e.g. vaccinia (VACV), variola, cowpox, and monkeypox viruses] encode both R1 and R2 subunits, the vast majority of Chordopoxviruses encode only R2 subunits. Using plaque morphology, growth curve, and mouse model studies, we investigated the requirement of VACV R1 (I4) and R2 (F4) subunits for replication and pathogenesis using a panel of mutant viruses in which one or more viral RR genes had been inactivated. Surprisingly, VACV F4, but not I4, was required for efficient replication in culture and virulence in mice. The growth defects of VACV strains lacking F4 could be complemented by genes encoding other Chordopoxvirus R2 subunits, suggesting conservation of function between poxvirus R2 proteins. Expression of F4 proteins encoding a point mutation predicted to inactivate RR activity but still allow for interaction with R1 subunits, caused a dominant negative phenotype in growth experiments in the presence or absence of I4. Co-immunoprecipitation studies showed that F4 (as well as other Chordopoxvirus R2 subunits) form hybrid complexes with cellular R1 subunits. Mutant F4 proteins that are unable to interact with host R1 subunits failed to rescue the replication defect of strains lacking F4, suggesting that F4-host R1 complex formation is critical for VACV replication. Our results suggest that poxvirus R2 subunits form functional complexes with host R1 subunits to provide sufficient dNTPs for viral replication. Our results also suggest that R2-deficient poxviruses may be selective oncolytic agents and our bioinformatic analyses provide insights into how poxvirus nucleotide metabolism proteins may have influenced the base composition of these pathogens.
Zdroje
1. NordlundP
ReichardP
2006
Ribonucleotide reductases.
Annu Rev Biochem
75
681
706
2. KolbergM
StrandKR
GraffP
AnderssonKK
2004
Structure, function, and mechanism of ribonucleotide reductases.
Biochim Biophys Acta
1699
1
34
3. TorrentsE
TrevisiolC
RotteC
HellmanU
MartinW
2006
Euglena gracilis ribonucleotide reductase: the eukaryote class II enzyme and the possible antiquity of eukaryote B12 dependence.
J Biol Chem
281
5604
5611
4. RovaU
AdraitA
PotschS
GraslundA
ThelanderL
1999
Evidence by mutagenesis that Tyr(370) of the mouse ribonucleotide reductase R2 protein is the connecting link in the intersubunit radical transfer pathway.
J Biol Chem
274
23746
23751
5. HimoF
SiegbahnPE
2003
Quantum chemical studies of radical-containing enzymes.
Chem Rev
103
2421
2456
6. StubbeJ
NoceraDG
YeeCS
ChangMC
2003
Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer?
Chem Rev
103
2167
2201
7. NordlundP
SjobergBM
EklundH
1990
Three-dimensional structure of the free radical protein of ribonucleotide reductase.
Nature
345
593
598
8. RovaU
GoodtzovaK
IngemarsonR
BehravanG
GraslundA
1995
Evidence by site-directed mutagenesis supports long-range electron transfer in mouse ribonucleotide reductase.
Biochemistry
34
4267
4275
9. LarssonA
SjobergBM
1986
Identification of the stable free radical tyrosine residue in ribonucleotide reductase.
EMBO J
5
2037
2040
10. EkbergM
SahlinM
ErikssonM
SjobergBM
1996
Two conserved tyrosine residues in protein R1 participate in an intermolecular electron transfer in ribonucleotide reductase.
J Biol Chem
271
20655
20659
11. ClimentI
SjobergBM
HuangCY
1992
Site-directed mutagenesis and deletion of the carboxyl terminus of Escherichia coli ribonucleotide reductase protein R2. Effects on catalytic activity and subunit interaction.
Biochemistry
31
4801
4807
12. BjorklundS
SkogS
TribukaitB
ThelanderL
1990
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.
Biochemistry
29
5452
5458
13. EngstromY
ErikssonS
JildevikI
SkogS
ThelanderL
1985
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits.
J Biol Chem
260
9114
9116
14. ChabesAL
BjorklundS
ThelanderL
2004
S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region.
J Biol Chem
279
10796
10807
15. ChabesAL
PflegerCM
KirschnerMW
ThelanderL
2003
Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis.
Proc Natl Acad Sci U S A
100
3925
3929
16. TanakaH
ArakawaH
YamaguchiT
ShiraishiK
FukudaS
2000
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Nature
404
42
49
17. GuittetO
HakanssonP
VoevodskayaN
FriddS
GraslundA
2001
Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.
J Biol Chem
276
40647
40651
18. WangX
ZhenchukA
WimanKG
AlbertioniF
2009
Regulation of p53R2 and its role as potential target for cancer therapy.
Cancer Lett
276
1
7
19. BourdonA
MinaiL
SerreV
JaisJP
SarziE
2007
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.
Nat Genet
39
776
780
20. HakanssonP
HoferA
ThelanderL
2006
Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.
J Biol Chem
281
7834
7841
21. TidonaCA
DaraiG
2000
Iridovirus homologues of cellular genes–implications for the molecular evolution of large DNA viruses.
Virus Genes
21
77
81
22. BoursnellM
ShawK
YanezRJ
VinuelaE
DixonL
1991
The sequences of the ribonucleotide reductase genes from African swine fever virus show considerable homology with those of the orthopoxvirus, vaccinia virus.
Virology
184
411
416
23. FrameMC
MarsdenHS
DutiaBM
1985
The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K).
J Gen Virol
66(Pt 7)
1581
1587
24. SlabaughM
RosemanN
DavisR
MathewsC
1988
Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants.
J Virol
62
519
527
25. TengelsenLA
SlabaughMB
BiblerJK
HrubyDE
1988
Nucleotide sequence and molecular genetic analysis of the large subunit of ribonucleotide reductase encoded by vaccinia virus.
Virology
164
121
131
26. ElfordHL
FreeseM
PassamaniE
MorrisHP
1970
Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.
J Biol Chem
245
5228
5233
27. ParkerS
NuaraA
BullerRM
SchultzDA
2007
Human monkeypox: an emerging zoonotic disease.
Future Microbiol
2
17
34
28. VorouRM
PapavassiliouVG
PierroutsakosIN
2008
Cowpox virus infection: an emerging health threat.
Curr Opin Infect Dis
21
153
156
29. SlabaughMB
JohnsonTL
MathewsCK
1984
Vaccinia virus induces ribonucleotide reductase in primate cells.
J Virol
52
507
514
30. SchmittJF
StunnenbergHG
1988
Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment.
J Virol
62
1889
1897
31. SlabaughMB
MathewsCK
1984
Vaccinia virus-induced ribonucleotide reductase can be distinguished from host cell activity.
J Virol
52
501
506
32. HendricksSP
MathewsCK
1998
Allosteric regulation of vaccinia virus ribonucleotide reductase, analyzed by simultaneous monitoring of its four activities.
J Biol Chem
273
29512
29518
33. ChimployK
MathewsCK
2001
Mouse ribonucleotide reductase control: influence of substrate binding upon interactions with allosteric effectors.
J Biol Chem
276
7093
7100
34. ChildSJ
PalumboGJ
BullerRM
HrubyDE
1990
Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo.
Virology
174
625
629
35. RajagopalI
AhnBY
MossB
MathewsCK
1995
Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis.
J Biol Chem
270
27415
27418
36. HowleyPM
SpehnerD
DrillienR
1996
A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus.
Gene
172
233
237
37. LeeMS
RoosJM
McGuiganLC
SmithKA
CormierN
1992
Molecular attenuation of vaccinia virus: mutant generation and animal characterization.
J Virol
66
2617
2630
38. GammonDB
EvansDH
2009
The 3′-to-5′ exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.
J Virol
83
4236
4250
39. BlackME
HrubyDE
1992
A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.
J Biol Chem
267
9743
9748
40. LinYC
LiJ
IrwinCR
JenkinsH
DeLangeL
2008
Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.
J Virol
82
5922
5932
41. ParanN
De SilvaFS
SenkevichTG
MossB
2009
Cellular DNA ligase I is recruited to cytoplasmic vaccinia virus factories and masks the role of the vaccinia ligase in viral DNA replication.
Cell Host Microbe
6
563
569
42. RosemanNA
SlabaughMB
1990
The vaccinia virus HindIII F fragment: nucleotide sequence of the left 6.2 kb.
Virology
178
410
418
43. XueL
ZhouB
LiuX
WangT
ShihJ
2006
Structurally dependent redox property of ribonucleotide reductase subunit p53R2.
Cancer Res
66
1900
1905
44. SlabaughMB
MathewsCK
1986
Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase.
J Virol
60
506
514
45. DuxburyMS
ItoH
BenoitE
ZinnerMJ
AshleySW
2004
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.
Surgery
136
261
269
46. CihlarT
ChenMS
1996
Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
Mol Pharmacol
50
1502
1510
47. XiongX
SmithJL
KimC
HuangES
ChenMS
1996
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.
Biochem Pharmacol
51
1563
1567
48. MageeWC
HostetlerKY
EvansDH
2005
Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
Antimicrob Agents Chemother
49
3153
3162
49. MageeWC
AldernKA
HostetlerKY
EvansDH
2008
Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
Antimicrob Agents Chemother
52
586
597
50. KernER
PrichardMN
QuenelleDC
KeithKA
TiwariKN
2009
Activities of certain 5-substituted 4′-thiopyrimidine nucleosides against orthopoxvirus infections.
Antimicrob Agents Chemother
53
572
579
51. PrichardMN
KeithKA
JohnsonMP
HardenEA
McBrayerA
2007
Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.
Antimicrob Agents Chemother
51
1795
1803
52. TaddieJA
TraktmanP
1993
Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3′-5′ exonuclease domain.
J Virol
67
4323
4336
53. CresawnSG
PrinsC
LatnerDR
ConditRC
2007
Mapping and phenotypic analysis of spontaneous isatin-beta-thiosemicarbazone resistant mutants of vaccinia virus.
Virology
363
319
332
54. EngstromY
RozellB
1988
Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase.
EMBO J
7
1615
1620
55. PontarinG
FijolekA
PizzoP
FerraroP
RampazzoC
2008
Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage.
Proc Natl Acad Sci U S A
105
17801
17806
56. EngstromY
RozellB
HanssonHA
StemmeS
ThelanderL
1984
Localization of ribonucleotide reductase in mammalian cells.
EMBO J
3
863
867
57. FisherA
YangFD
RubinH
CoopermanBS
1993
R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase.
J Med Chem
36
3859
3862
58. PenderBA
WuX
AxelsenPH
CoopermanBS
2001
Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies.
J Med Chem
44
36
46
59. UhlinU
EklundH
1994
Structure of ribonucleotide reductase protein R1.
Nature
370
533
539
60. LiuzziM
DezielR
MossN
BeaulieuP
BonneauAM
1994
A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
Nature
372
695
698
61. UppstenM
FarnegardhM
DomkinV
UhlinU
2006
The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.
J Mol Biol
359
365
377
62. DuxburyMS
ItoH
ZinnerMJ
AshleySW
WhangEE
2004
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
Oncogene
23
1539
1548
63. LemboD
BruneW
2009
Tinkering with a viral ribonucleotide reductase.
Trends Biochem Sci
34
25
32
64. PontarinG
FerraroP
HakanssonP
ThelanderL
ReichardP
2007
p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage.
J Biol Chem
282
16820
16828
65. KimuraT
TakedaS
SagiyaY
GotohM
NakamuraY
2003
Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools.
Nat Genet
34
440
445
66. de WindN
BernsA
GielkensA
KimmanT
1993
Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity.
J Gen Virol
74(Pt 3)
351
359
67. CameronJM
McDougallI
MarsdenHS
PrestonVG
RyanDM
1988
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target.
J Gen Virol
69(Pt 10)
2607
2612
68. JacobsonJG
LeibDA
GoldsteinDJ
BogardCL
SchafferPA
1989
A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells.
Virology
173
276
283
69. HeinemanTC
CohenJI
1994
Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro.
J Virol
68
3317
3323
70. McClementsW
YamanakaG
GarskyV
PerryH
BacchettiS
1988
Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.
Virology
162
270
273
71. DutiaBM
FrameMC
Subak-SharpeJH
ClarkWN
MarsdenHS
1986
Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Nature
321
439
441
72. CoopermanBS
2003
Oligopeptide inhibition of class I ribonucleotide reductases.
Biopolymers
71
117
131
73. PatroneM
PercivalleE
SecchiM
FiorinaL
Pedrali-NoyG
2003
The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection.
J Gen Virol
84
3359
3370
74. SunY
ConnerJ
1999
The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit.
J Gen Virol
80(Pt 10)
2713
2718
75. LemboD
DonalisioM
HoferA
CornagliaM
BruneW
2004
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis.
J Virol
78
4278
4288
76. LemboD
GribaudoG
HoferA
RieraL
CornagliaM
2000
Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.
J Virol
74
11557
11565
77. BruneW
MenardC
HeesemannJ
KoszinowskiUH
2001
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism.
Science
291
303
305
78. WilliamsT
Barbosa-SolomieuV
ChincharVG
2005
A decade of advances in iridovirus research.
Adv Virus Res
65
173
248
79. LundinD
TorrentsE
FurrerE
Larsson BirganderP
SahlinM
PooleAM
SjöbergBM
2005
RNRdb: The ribonucleotide reductase database. version 1.0.
Dept of Molecular Biology & Functional Genetics, Stockholm University, Stockholm, Sweden http://rnrdb.molbio.su.se
80. TulmanER
DelhonG
AfonsoCL
LuZ
ZsakL
2006
Genome of horsepox virus.
J Virol
80
9244
9258
81. CameronC
Hota-MitchellS
ChenL
BarrettJ
CaoJX
1999
The complete DNA sequence of myxoma virus.
Virology
264
298
318
82. WillerDO
McFaddenG
EvansDH
1999
The complete genome sequence of shope (rabbit) fibroma virus.
Virology
264
319
343
83. XueL
ZhouB
LiuX
QiuW
JinZ
2003
Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Cancer Res
63
980
986
84. XueL
ZhouB
LiuX
HeungY
ChauJ
2007
Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Cancer Res
67
16
21
85. PiaoC
JinM
KimHB
LeeSM
AmatyaPN
2009
Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Oncogene
28
2173
2184
86. AndradeAA
SilvaPN
PereiraAC
De SousaLP
FerreiraPC
2004
The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
Biochem J
381
437
446
87. BratkeKA
McLysaghtA
2008
Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach.
BMC Evol Biol
8
67
88. FileeJ
PougetN
ChandlerM
2008
Phylogenetic evidence for extensive lateral acquisition of cellular genes by Nucleocytoplasmic large DNA viruses.
BMC Evol Biol
8
320
89. FileeJ
BaptesteE
SuskoE
KrischHM
2006
A selective barrier to horizontal gene transfer in the T4-type bacteriophages that has preserved a core genome with the viral replication and structural genes.
Mol Biol Evol
23
1688
1696
90. JordanA
TorrentsE
SalaI
HellmanU
GibertI
1999
Ribonucleotide reduction in Pseudomonas species: simultaneous presence of active enzymes from different classes.
J Bacteriol
181
3974
3980
91. HughesAL
FriedmanR
2003
Genome-wide survey for genes horizontally transferred from cellular organisms to baculoviruses.
Mol Biol Evol
20
979
987
92. HowellML
RosemanNA
SlabaughMB
MathewsCK
1993
Vaccinia virus ribonucleotide reductase. Correlation between deoxyribonucleotide supply and demand.
J Biol Chem
268
7155
7162
93. SlabaughMB
DavisRE
RosemanNA
MathewsCK
1993
Vaccinia virus ribonucleotide reductase expression and isolation of the recombinant large subunit.
J Biol Chem
268
17803
17810
94. SouglakosJ
BoukovinasI
TaronM
MendezP
MavroudisD
2008
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
Br J Cancer
98
1710
1715
95. WrightJA
AlamTG
McClartyGA
TaggerAY
ThelanderL
1987
Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat, and human cell lines.
Somat Cell Mol Genet
13
155
165
96. RosellR
FelipE
TaronM
MajoJ
MendezP
2004
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Clin Cancer Res
10
4215s
4219s
97. YoonSS
CarrollNM
ChioccaEA
TanabeKK
1998
Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.
Ann Surg
228
366
374
98. SpearMA
SunF
ElingDJ
GilpinE
KippsTJ
2000
Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation.
Cancer Gene Ther
7
1051
1059
99. StanfordMM
McFaddenG
2007
Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.
Expert Opin Biol Ther
7
1415
1425
100. WooY
KellyKJ
StanfordMM
GalanisC
ChunYS
2008
Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells.
Ann Surg Oncol
15
2329
2335
101. HuY
LeeJ
McCartJA
XuH
MossB
2001
Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.
J Virol
75
10300
10308
102. MoM
FlemingSB
MercerAA
2009
Cell cycle deregulation by a poxvirus partial mimic of anaphase-promoting complex subunit 11.
Proc Natl Acad Sci U S A
106
19527
19532
103. KePY
ChangZF
2004
Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway.
Mol Cell Biol
24
514
526
104. McFaddenG
2005
Poxvirus tropism.
Nat Rev Microbiol
3
201
213
105. AndreiG
GammonDB
FitenP
De ClercqE
OpdenakkerG
2006
Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.
J Virol
80
9391
9401
106. DeMasiJ
TraktmanP
2000
Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis.
J Virol
74
2393
2405
107. FalknerFG
MossB
1988
Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
J Virol
62
1849
1854
108. WasilenkoST
StewartTL
MeyersAF
BarryM
2003
Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis.
Proc Natl Acad Sci U S A
100
14345
14350
109. DvoracekB
ShorsT
2003
Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression.
Plasmid
49
9
17
110. ChakrabartiS
SislerJR
MossB
1997
Compact, synthetic, vaccinia virus early/late promoter for protein expression.
Biotechniques
23
1094
1097
111. TulmanER
AfonsoCL
LuZ
ZsakL
KutishGF
2004
The genome of canarypox virus.
J Virol
78
353
366
112. UptonC
HoggD
PerrinD
BooneM
HarrisNL
2000
Viral genome organizer: a system for analyzing complete viral genomes.
Virus Res
70
55
64
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- RNA Virus Replication Complexes
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- Functional Genetic Diversity among Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites